Valuation: Macter International Limited

Market Cap 12.55B 45.25M 38.76M 36.27M 33.2M 62.3M 4.33B 63.13M 428M 167M 2.17B 170M 166M 7.19B P/E 2024
10.6x
P/E 2025 29.5x
Enterprise Value 13.27B 47.83M 40.97M 38.34M 35.09M 65.86M 4.58B 66.73M 453M 177M 2.3B 180M 176M 7.6B EV / Sales 2024
0.6x
EV / Sales 2025 2.28x
Free-Float
19.17%
Yield 2024
2.39%
Yield 2025 0.76%
1 day-0.53%
1 week-1.27%
Current month-1.00%
1 month-3.86%
3 months+2.94%
6 months-13.73%
Current year-16.90%
1 week 273
Extreme 273
283
1 month 273
Extreme 273
290
Current year 255.1
Extreme 255.1
364.97
1 year 255.1
Extreme 255.1
443.5
3 years 75.75
Extreme 75.75
621.82
5 years 75.75
Extreme 75.75
621.82
10 years 53.1
Extreme 53.1
621.82
Manager TitleAgeSince
Chief Executive Officer - 1993-12-31
Director of Finance/CFO - 2024-01-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 1991-12-31
Chairman - 1993-12-31
Director/Board Member - 2010-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.27%-32.30%+181.48% 45.56M
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +1.11%+4.34%+25.11%+66.25% 379.99B
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2024 2025
Net sales 7.97B 28.75M 24.63M 23.04M 21.09M 39.59M 2.75B 40.11M 272M 106M 1.38B 108M 106M 4.57B 10.36B 37.35M 31.99M 29.94M 27.4M 51.43M 3.57B 52.11M 354M 138M 1.8B 140M 137M 5.94B
Net income 407M 1.47M 1.26M 1.18M 1.08M 2.02M 140M 2.05M 13.88M 5.41M 70.47M 5.51M 5.39M 233M 776M 2.8M 2.4M 2.24M 2.05M 3.85M 268M 3.91M 26.51M 10.34M 135M 10.51M 10.28M 445M
Net Debt 495M 1.79M 1.53M 1.43M 1.31M 2.46M 171M 2.49M 16.91M 6.59M 85.82M 6.7M 6.56M 284M 717M 2.59M 2.22M 2.07M 1.9M 3.56M 247M 3.61M 24.49M 9.55M 124M 9.71M 9.5M 411M
Logo Macter International Limited
Macter International Limited is a Pakistan-based pharmaceutical company. The principal activity of the Company is to manufacture and market pharmaceutical products. The Company’s business areas are contract manufacturing and branded generic formulations. Its segments include Pharmaceuticals and Cosmetics and Fragrance. It is a contract manufacturer for multinational companies, which offers a range of dosage forms: oral solids and liquids, parenteral (ampules and vials), topicals, metered dose inhalers, and ear and eye drops. The Company produces specialty products at its plant, which include solid and liquid oral dosage forms (tablets, capsules, syrups, suspensions, and dry powder), injections (sterile liquid vials, sterile liquid ampoules, and sterile dry powders), ointments and creams, drops, and inhalers. Its manufacturing operations include formulation, vial filling, lyophilization, and packaging of biological drugs.
Employees
1,282
Date Price Change Volume
26-08-21 PKR 275.85 -0.53% 7,899
26-08-20 PKR 277.32 -0.01% 2,719
26-08-19 PKR 277.36 +0.80% 4,388
26-08-18 PKR 275.17 -1.62% 10,366
26-08-17 PKR 279.70 +0.11% 14,552
  1. Stock Market
  2. Stocks
  3. MACTER Stock